Match Document Document Title
7619110 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof  
The present invention provides a prodrug of propofol and crystalline forms thereof, methods of making the propofol prodrug and crystalline forms thereof, pharmaceutical compositions of the propofol...
7612087 Heterocyclic compounds as inhibitors of beta-lactamases  
This invention discloses and claims methods for inhibiting bacterial β-lactamases and treating bacterial infections by inhibiting bacterial β-lactamases in man or an animal comprising...
7612085 Sigma 2 receptor ligands and therapeutic uses therefor  
A series of N-substituted 9-azabicyclo[3.3.1]nonan-3α-yl phenylcarbamate analogs are disclosed, as well as methods of their preparation. Their affinities for sigma (σ1 and σ2) receptors are...
7612084 Amine derivatives for the treatment of asthma and COPD  
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
7608626 Substituted indolizines and derivatives as CNS agents  
Compounds of formula 1 or pharmaceutically acceptable salts thereof are provided: which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and...
7601735 Antiviral compounds  
Use of certain castanospermine esters in the treatment of diseases caused by flaviviruses, in particular in the treatment of disease caused by the hepatitis C virus (HCV) and compositions...
7598233 Method for treating thrombosis  
This invention relates to a method for treating thrombosis by combined administration of a pitavastatin with aspirin.
7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5  
Tetrazole compounds substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring,...
7585874 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives  
The present invention is concerned with aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives of formula I: wherein R 1 to R 5 are as defined in the specification and pharmaceutically...
7582650 Tricyclic opioid modulators  
The invention is directed to compounds of Formula (I) useful as delta and mu opioid receptor modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and...
7572798 Combi-molecules having signal transduction inhibitory properties and DNA damaging properties  
The present invention relates to a series of new chemical agents that demonstrate anti-tumor activity. More particularly, the present invention relates to molecules, referred to as...
7563774 Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes  
A combination therapy of at least one FBPase inhibitor and at least one other antidiabetic agent is disclosed.
RE40838 2-azabicyclo[3.3.1]nonane derivatives  
The subject invention relates to 2-azabicyclo[3.3.1]nonane derivatives, pharmaceutical compositions comprising such derivatives and methods of using such derivatives to treat disease states,...
7553846 2-alkylbenzoxazole carboxamides as 5-HT3 modulators  
Compounds of formulae I and II: are disclosed as 5-HT 3 inhibitors. Those compounds are useful in treating CINV, IBS-D and other diseases and conditions.
7553845 Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives  
The invention is directed to a compound of formula I, wherein R, R 1 , R 2 , R 3 and R 4 are as defined herein, or a pharmaceutically acceptable salt thereof, and its pharmaceutically...
7553844 Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors  
The present invention relates to a drug combination capable of conferring therapeutic benefits in the treatment of both AIDS and malaria. In particular, it relates to a drug combination including...
7524958 Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors  
This invention relates to novel 9-aza-bicyclo[3.3.1]nonane derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these...
7524858 Substituted pyrroline kinase inhibitors  
The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
7517988 Hydroxamates as therapeutic agents  
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore...
7511058 Heterocyclic inhibitors of MEK and methods of use thereof  
Disclosed are compounds of the Formula III and pharmaceutically acceptable salts and prodrugs thereof, wherein R 1 , R 2 , R 7 , R 8 , R 9 R 10 , and W are as defined in the specification....
7488735 Quinuclidine amide derivatives  
New quinuclidine amide derivatives having the chemical structure of general formula (I) and pharmaceutically acceptable salts thereof including quaternary salts of formula (II) are disclosed; as...
7479498 Treatments for viral infections  
The present invention relates to improved methods and compositions for treating viral infections and other diseases and conditions that induce a cytokine storm. More particularly, the present...
7449582 Compounds and compositions as protein kinase inhibitors  
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated...
7442708 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same  
Compounds of formula I or salts thereof: in which R 1 represents —OH, (C 1 -C 5 )alkoxy, carboxyl, (C 2 -C 6 )alkoxycarbonyl, —NR 5 R 6 , —NH—SO 2 -Alk, —NH—SO 2 -Ph,...
7435742 Quinuclidine derivatives and pharmaceutical compositions containing the same  
Carbamates of formula (I) or pharmaceutically acceptable salts thereof, including quaternary ammonium salts of formula (II) are disclosed; as well as processes for their preparation, pharmaceutical...
7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof  
The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally...
7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors  
Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described....
7411076 Coumarin derivative  
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula...
7410978 Once daily dosage forms of trospium  
A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C...
7410961 2,6-disubstituted piperiddines as modulators  
The present invention is further directed to compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 and R 22 are as...
7402592 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders  
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release...
7399769 Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives  
The present invention is concerned with aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives of formula wherein: R 1 , R 2 , and R 3 are as defined herein and pharmaceutically acceptable...
7399749 Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease  
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses...
7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases  
The present invention relates to a new use for compounds having 5-HT 3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for...
7388018 4-Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents  
Sulfonamides of the formula I where the substituents are as follows: R 1 is hydrogen, alkyl, alkoxy, alkenyl or alkynyl; and R 2 , R 3 , R 4 , R 5 are hydrogen, halogen, alkyl, alkoxy or...
7384954 4-substituted imidazoles  
Compounds of formula I: wherein A and R 1 are as defined in the specification, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially in...
7342028 Medical use for tachykinin antagonists  
The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel...
7320987 6-Alkoxy-pyrido-pyrimidines  
The present invention provides compounds of the Formula I: wherein R 1 is alkyl, cycloalkyl, cycloalkylalkyl, or —CH 2 -alkenyl, X 1 is O, NH, N(alkyl), S or —C(═O), Z is N or CH; and R...
7314870 Compounds, their preparation and use  
The present invention relates to novel compounds that are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due...
7312230 Carboxylic acid derivatives as IP antagonists  
This invention relates to compounds which are generally IP receptor antagonists and which are represented by Formula I: wherein: R 1 , R 2 , and R 3 are each independently in each...
7297693 Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors  
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac...
7276520 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists  
Certain novel bicyclic N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R)....
7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease  
The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life...
7273865 Thiazolopyridine  
The present invention relates to compounds of formula I wherein R 1 and R 2 are described hereinbelow. These compounds have high affinity to A 2A receptors and good selectivity to A 1 and A...
7241773 3-quinuclidinyl heteroatom bridged biaryl derivatives  
Compounds of formula: or pharmaceutically acceptable salts, esters, amides, or prodrugs thereof, wherein: A and G are each independently N or N + —O − ; m and n are each independently 0, 1,...
7230009 Pyridoxal analogues and methods of treatment  
Pyridoxal analogues can be useful for treating B 6 deficiency and related diseases; cardiovascular and related diseases; melanoma and related diseases; and symptoms thereof. One such analogue is a...
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7205328 Oxindoles with anti-HIV activity  
The present invention relates to inhibition of viruses, e.g., HIV using oxindoles and compounds related to oxindoles. The invention further relates to methods for identifying and using agents,...
RE39558 5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosis  
Compounds of this formula are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease  
The invention provides compounds of Formula I: wherein Azabicyclo is where the variables have the definitions discussed herein. These compounds may be in the form of pharmaceutical salts or...